Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
P2.14-51 Dual ALK Fusion Partners as Poor Predictive Marker in First Line Crizotinib Treated ALK Rearranged Non-Small Cell Lung Cancer
PaperCitations, authors & open-access status
P2.14-51 Dual ALK Fusion Partners as Poor Predictive Marker in First Line Crizotinib Treated ALK Rearranged Non-Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2 citations, 2019 year and closed oa status.
2
Citations
2019
Year
closed
OA Status